ATE243703T1 - Antibiotische azalid-zusammensetzungen - Google Patents

Antibiotische azalid-zusammensetzungen

Info

Publication number
ATE243703T1
ATE243703T1 AT00979850T AT00979850T ATE243703T1 AT E243703 T1 ATE243703 T1 AT E243703T1 AT 00979850 T AT00979850 T AT 00979850T AT 00979850 T AT00979850 T AT 00979850T AT E243703 T1 ATE243703 T1 AT E243703T1
Authority
AT
Austria
Prior art keywords
antibiotic
azalide
compositions
azalide compositions
antibiotic azalide
Prior art date
Application number
AT00979850T
Other languages
English (en)
Inventor
Wayne Alan Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22652702&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE243703(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE243703T1 publication Critical patent/ATE243703T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00979850T 2000-01-27 2000-11-30 Antibiotische azalid-zusammensetzungen ATE243703T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17848100P 2000-01-27 2000-01-27
PCT/IB2000/001824 WO2001055158A1 (en) 2000-01-27 2000-11-30 Azalide antibiotic compositions

Publications (1)

Publication Number Publication Date
ATE243703T1 true ATE243703T1 (de) 2003-07-15

Family

ID=22652702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00979850T ATE243703T1 (de) 2000-01-27 2000-11-30 Antibiotische azalid-zusammensetzungen

Country Status (21)

Country Link
US (2) US6514945B1 (de)
EP (1) EP1250343B1 (de)
JP (2) JP3893059B2 (de)
AR (2) AR030045A1 (de)
AT (1) ATE243703T1 (de)
AU (1) AU779748C (de)
BR (2) BRPI0017013B8 (de)
CA (1) CA2398485C (de)
CO (1) CO5251404A1 (de)
DE (1) DE60003586T2 (de)
DK (1) DK1250343T3 (de)
ES (1) ES2199884T3 (de)
MX (1) MXPA02007305A (de)
NZ (1) NZ518665A (de)
PA (1) PA8509801A1 (de)
PE (1) PE20011050A1 (de)
PT (1) PT1250343E (de)
TN (1) TNSN01017A1 (de)
TW (2) TWI318880B (de)
WO (1) WO2001055158A1 (de)
ZA (1) ZA200205958B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
US7312248B2 (en) 2004-09-23 2007-12-25 Schering-Plough Animal Health Corporation Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
WO2006055565A2 (en) * 2004-11-19 2006-05-26 Schering-Plough Ltd. Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
CA2609574A1 (en) * 2005-06-09 2006-12-21 Schering-Plough Ltd. Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
US20080044455A1 (en) * 2006-08-21 2008-02-21 Chaim Welczer Tonsillitus Treatment
WO2008076256A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
MX2009006282A (es) * 2006-12-13 2009-06-23 Schering Plough Ltd Profarmacos solubles en agua de florfenicol y sus analogos.
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
KR101714291B1 (ko) 2007-06-27 2017-03-08 이 아이 듀폰 디 네모아 앤드 캄파니 동물 해충 방제 방법
US7795231B2 (en) * 2007-10-04 2010-09-14 Insite Vision Incorporated Concentrated aqueous azalide formulations
TWI468407B (zh) 2008-02-06 2015-01-11 Du Pont 中離子農藥
CA2732017A1 (en) * 2008-07-30 2010-02-04 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
CN102686570A (zh) 2009-08-05 2012-09-19 杜邦公司 介离子杀虫剂
MX2012001646A (es) 2009-08-05 2012-03-21 Du Pont Pesticidas mesoionicos.
MX2012013758A (es) 2010-05-27 2013-01-24 Du Pont Forma cristalina de 4-[5-[3-cloro-5-trifluorometil)fenil]-4,5-dihi dro-5-(trifluorometil)-3-isoxazolil]-n-[2-oxo-2-[(2,2,2-trifluoro etil)amino]etil]-1-naftalenocarboxamida.
WO2012001089A1 (en) 2010-07-01 2012-01-05 Novartis Ag Antibiotic compositions
EP2595634B1 (de) * 2010-07-23 2016-09-14 Acea Biotech, Inc. Antimykotische und antiparasitäre polyenmakrolide
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
CN103619818A (zh) 2011-06-20 2014-03-05 纳幕尔杜邦公司 用于治疗蠕虫感染的杂环化合物
EP2736915A1 (de) 2011-07-27 2014-06-04 Farma GRS, d.o.o. Neue kristalline formen von tulathromycin
CA2853284C (en) 2011-11-11 2018-08-28 Exxonmobil Upstream Research Company Exploration method and system for detection of hydrocarbons
WO2013071189A1 (en) 2011-11-11 2013-05-16 Exxonmobil Upstream Research Company Method and system for reservoir surveillance utilizing a clumped isotope and/or noble gas data
CN103958476A (zh) 2011-11-28 2014-07-30 纳幕尔杜邦公司 N-(4-喹啉基甲基)磺酰胺衍生物以及它们作为驱肠虫剂的用途
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
KR102363621B1 (ko) 2013-04-04 2022-02-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 매크롤라이드 그리고 그의 제조방법 및 용도
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
BR112016015869A8 (pt) 2014-03-07 2023-04-04 Exxonmobil Upstream Res Co Método para detectar hidrocarbonetos e sistema de computador para detectar hidrocarbonetos
CN104119413B (zh) * 2014-07-29 2016-08-24 华中农业大学 一种土拉霉素残留标示物的合成方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
JP2018509452A (ja) 2015-03-25 2018-04-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 修飾デソサミン糖をもつマクロライドおよびその使用
US10414746B2 (en) * 2016-01-18 2019-09-17 Zhejiang Hisun Pharmaceutical Co., Ltd. Method and intermediate for preparing tulathromycin
CN113646319A (zh) * 2018-11-19 2021-11-12 齐卡尼治疗股份有限公司 C11-环取代的13元大环内酯及其用途
AU2021232959B2 (en) 2020-03-12 2023-09-07 Zoetis Services Llc Immunomodulating urea azalides
KR20240056746A (ko) 2021-09-07 2024-04-30 조에티스 서비시즈 엘엘씨 면역조정성 아잘라이드

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6128174A (en) 1997-08-29 2000-10-03 Stereotaxis, Inc. Method and apparatus for rapidly changing a magnetic field produced by electromagnets
NZ502861A (en) * 1997-09-10 2001-03-30 Merck & Co Inc Method of treating livestock bacterial respiratory or enteric infections using 9a-azalides
YU76601A (sh) * 1999-05-18 2004-09-03 Pfizer Products Inc. Novi kristalni oblici makrolidnog antibiotika

Also Published As

Publication number Publication date
CA2398485A1 (en) 2001-08-02
AR030045A1 (es) 2003-08-13
BR0017013A2 (pt) 2010-07-13
JP2006282676A (ja) 2006-10-19
AU779748C (en) 2005-12-08
DE60003586T2 (de) 2004-01-08
US6667393B2 (en) 2003-12-23
ZA200205958B (en) 2003-09-29
PE20011050A1 (es) 2001-10-19
EP1250343B1 (de) 2003-06-25
MXPA02007305A (es) 2002-11-29
CO5251404A1 (es) 2003-02-28
PA8509801A1 (es) 2002-02-21
BRPI0017013B8 (pt) 2022-11-16
CA2398485C (en) 2008-01-29
JP2004500384A (ja) 2004-01-08
NZ518665A (en) 2005-02-25
TWI318880B (en) 2010-01-01
BR0017013A (pt) 2002-10-22
AR039387A2 (es) 2005-02-16
EP1250343A1 (de) 2002-10-23
ES2199884T3 (es) 2004-03-01
BRPI0017013B1 (pt) 2015-07-14
US6514945B1 (en) 2003-02-04
AU1722801A (en) 2001-08-07
TW201006476A (en) 2010-02-16
US20030013860A1 (en) 2003-01-16
DK1250343T3 (da) 2003-09-22
PT1250343E (pt) 2003-11-28
WO2001055158A1 (en) 2001-08-02
TNSN01017A1 (fr) 2005-11-10
DE60003586D1 (de) 2003-07-31
AU779748B2 (en) 2005-02-10
US20030073825A1 (en) 2003-04-17
TWI331527B (en) 2010-10-11
JP3893059B2 (ja) 2007-03-14

Similar Documents

Publication Publication Date Title
DE60003586D1 (de) Antibiotische azalid-zusammensetzungen
ATE345350T1 (de) Makrolidantibiotika
ATE303787T1 (de) Schergelzusammensetzungen
DE60139185D1 (de) Vernetzbare perfluoroelastomarzusammensetzung
IS2932B (is) Fúlvestrant samsetning
AR028197A1 (es) Composiciones antitranspirantes
FI20105657A (fi) Farmaseuttisia koostumuksia
DE60131547D1 (de) Abführende zusammensetzungen
DK1147121T3 (da) Ketolidantibiotika
ITMI20010748A0 (it) Composizioni farmaceutiche
ATE246449T1 (de) Antimikrobielle zusammensetzungen
AR023440A1 (es) Composiciones antitranspirantes
ATE257691T1 (de) Schweisshemmende zusammensetzungen
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60133154D1 (de) Antistatische Zusammensetzung
DE60102050D1 (de) Glaszusammensetzung
NO20026123L (no) Farmasöytiske sammensetninger
NO20014362D0 (no) Erytromycinderivater
DE60116858D1 (de) Zusammensetzung
NO20031095D0 (no) Farmasöytiske sammensetninger
DE60139712D1 (de) Ionophore antibiotische formulierungen
AU2002317415A1 (en) Azalide antibiotic compositions
DE60107312D1 (de) Feste Zusammensetzung
DE50112620D1 (de) Anschlagpuffer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250343

Country of ref document: EP